EXCLI Journal publishes original research reports, authoritative reviews and case reports of experimental and clinical sciences.
EXCLI Journal (eISSN 1611-2156) is particularly keen to keep a broad view of science and technology, and therefore welcomes papers which bridge disciplines and may not suit the narrow specialism of other journals. Although the general emphasis is on biological sciences, studies from the following fields are explicitly encouraged:
Immunology, toxicology, ergonomics, neurosciences, psychology, occupational medicine, clinical and preclinical studies, drug development, pharmacology, environmental health, chemistry including analytical chemistry, biochemistry, cell biology, genetics, forensic medicine, oncology and cancer research, proteomics, systems biology, hepatology and gastroenterology, aging research, psychiatric research, behavioral sciences.
2022-01-18
In order to provide our readers with a visual and thus faster and easier overview of the content of a publication, we expect a graphical summary (where possible) to be provided by the author from mid-2022.
However, we already encourage our authors to provide an additional graphical summary from now on.
2021-06-21
Since June 2021, ORCID* is mandatory for all authors when submitting to EXCLI Journal. It is desirable that the ORCID contains the (current) institution as minimum information, so that each author can be clearly assigned via the ORCID in the metadata.
If ORCID, addresses or e-mail addresses are missing or incorrect, we reserve the right to reject such submissions due to formal errors.
*ORCID (Open Researcher and Contributor ID) should speed up the submission process. This unique identifier for authors is included as a mandatory field for all contributors in the submission tool.
Vol. 21 (2022)
Published continuously
Published: 2022-01-03
A prospective study